A randomised phase III study in advanced oesophageal carcinoma to compare dysphagia in patients treated with radiotherapy versus chemo-radiotherapy.

People with cancer of the oesophagus (gullet) often have trouble swallowing. Radiotherapy can help improve this problem. Using chemotherapy together with radiotherapy may work better but has more side effects. This trial will determine if it is better to use radiotherapy by itself or together with chemotherapy.

Primary Sponsor

Trans Tasman Radiation Oncology Group (TROG)

Collaborating Groups

NCI CTG (ES 2)

Final Accrual

220

Trial Chairperson

Dr Michael Penniment, Royal Adelaide Hospital, SA

Trial Contact

sonya.stephens@health.sa.gov.au

Clinical Trial Registration

Related Post

24 February, 2026

First patient recruited for trial of new imaging modality for lung cancer

LATEST NEWS: 24 February 2026 The first Australian participant

Roland Towning, participant in TROG NINJA trial
3 February, 2026

Roland’s story

Roland TowningPort Stephens, NSW Roland Towning is taking part